Treatment of secondary depression in schizophrenia. A double-blind, placebo-controlled trial of amitriptyline added to perphenazine - PubMed (original) (raw)
Clinical Trial
Treatment of secondary depression in schizophrenia. A double-blind, placebo-controlled trial of amitriptyline added to perphenazine
B A Prusoff et al. Arch Gen Psychiatry. 1979 May.
Abstract
The combination of antidepressants and neuroleptics has been widely recommended and commonly used clinically for the schizophrenic patient who becomes depressed. However, the value of the combination for these patients has not been clearly demonstrated. This report presents results of a double-blind, randomized, placebo-controlled clinical trial designed to evaluate the combination of perphenazine and amitriptyline hydrochloride with that of perphenazine alone in the treatment of 35 ambulatory chronic schizophrenic patients in whom depressive symptoms developed. Results showed that the addition of amitriptyline to perphenazine, when compared with perphenazine alone, was more effective in reducing symptoms of depression after four months of treatment, but less effective in reducing thought disorder. The study concludes that the value of adding an antidepressant to the usual neuroleptic in the treatment of secondary depression in schizophrenia should be reviewed.
Similar articles
- A controlled clinical trial of amitriptyline added to perphenazine in the treatment of depressed schizophrenics [proceedings].
Prusoff BA, Williams DH, Weissman MM, Astrachan BM. Prusoff BA, et al. Psychopharmacol Bull. 1979 Apr;15(2):80-1. Psychopharmacol Bull. 1979. PMID: 373008 Clinical Trial. No abstract available. - Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients. A controled study of drug interaction.
Chouinard G, Annable L, Serrano M, Albert JM, Charette R. Chouinard G, et al. Arch Gen Psychiatry. 1975 Oct;32(10):1295-307. doi: 10.1001/archpsyc.1975.01760280093009. Arch Gen Psychiatry. 1975. PMID: 1101843 Clinical Trial. - The pharmacological treatment of delusional depression.
Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin I, Neil JF, Perel JM, Rossi AJ, Soloff PH. Spiker DG, et al. Am J Psychiatry. 1985 Apr;142(4):430-6. doi: 10.1176/ajp.142.4.430. Am J Psychiatry. 1985. PMID: 3883815 Clinical Trial. - [Pharmacological treatment of delusional depression].
Amore M, Giordani L, Giorgetti G, Zazzeri N. Amore M, et al. Minerva Psichiatr. 1996 Mar;37(1):29-33. Minerva Psichiatr. 1996. PMID: 8804200 Review. Italian. - Efficacy of ECT in affective and schizophrenic illness.
Greenblatt M. Greenblatt M. Am J Psychiatry. 1977 Sep;134(9):1001-5. doi: 10.1176/ajp.134.9.1001. Am J Psychiatry. 1977. PMID: 331967 Review.
Cited by
- Antidepressants for people with both schizophrenia and depression.
Whitehead C, Moss S, Cardno A, Lewis G. Whitehead C, et al. Cochrane Database Syst Rev. 2002;2002(2):CD002305. doi: 10.1002/14651858.CD002305. Cochrane Database Syst Rev. 2002. PMID: 12076447 Free PMC article. Review. - Antidepressants for the negative symptoms of schizophrenia.
Rummel C, Kissling W, Leucht S. Rummel C, et al. Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD005581. doi: 10.1002/14651858.CD005581.pub2. Cochrane Database Syst Rev. 2006. PMID: 16856105 Free PMC article. Review. - Pharmacological treatment of patients with schizophrenia. Past and present problems and potential future therapy.
Johnson DA. Johnson DA. Drugs. 1990 Apr;39(4):481-8. doi: 10.2165/00003495-199039040-00001. Drugs. 1990. PMID: 2190791 Review. No abstract available. - Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich.
Bandelow B, Müller P, Gaebel W, Köpcke W, Linden M, Müller-Spahn F, Pietzcker A, Reischies FM, Tegeler J. Bandelow B, et al. Eur Arch Psychiatry Clin Neurosci. 1990;240(2):113-20. doi: 10.1007/BF02189981. Eur Arch Psychiatry Clin Neurosci. 1990. PMID: 1981149 Clinical Trial. - Review: treatment of schizophrenia. State of the art.
Möller HJ. Möller HJ. Eur Arch Psychiatry Clin Neurosci. 1996;246(5):229-34. doi: 10.1007/BF02190273. Eur Arch Psychiatry Clin Neurosci. 1996. PMID: 8863000 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources